Both in Biotechnology
Vericel vs Beam Therapeutics
Over the past year VCEL returned +10.4% and BEAM returned +6.7%; their daily moves had a correlation of 0.21.
VCEL +10.4% BEAM +6.7%Growth of $1, one year, split-adjusted
| Metric | VCEL | BEAM |
|---|---|---|
| Price | $40.51 | $25.87 |
| Market cap | $2.07B | $2.67B |
| Today | +0.62% | −4.99% |
| 1 month | +0.9% | +5.6% |
| 6 months | +11.0% | −14.0% |
| Year to date | +12.5% | −6.7% |
| 1 year | +17.3% | +8.7% |
| Revenue growth (YoY) | +22.5% | −94.2% |
| Gross margin | 72.8% | 100.0% |
| Net margin | 2.8% | −25036.3% |
| P/E (TTM) | 85.6× | — |
| Price / sales | 6.8× | 17.1× |
| Net cash | $162.5M | $1.05B |
| Dividend yield | — | — |
| Volatility (60d) | 33.0% | 63.3% |
| Short % of float | 11.1% | 32.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).